Jade Biosciences


Jade Biosciences is developing a pipeline of potentially best-in-class therapies aimed at transforming the standard of care for patients living with autoimmune diseases.

Employees

11-50

Links


Org chart

Lawrence Klein
Chief Executive Officer, Oruka Therapeutics
Collapse
Tom Frohlich
Chief Executive Officer
Hetal Kocinsky
Chief Medical Officer
Andrew King
Chief Scientific Officer, Head Of R&d

Teams

This company has no teams yet


Offices

This company has no offices yet